Evidence map›Paper›PMID 37698786›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2024

Clinical and demographic characteristics of patients with NMOSD: a longitudinal retrospective analysis of a Slovak cohort of 63 patients.

Jarmila Szilasiová, Jakub Gazda, Pavol Mikula, Anna Cvengrošová, Miriam Fedičová, Viera Hančinová, Ema Kantorová, Martin Karlík, Slavomíra Kováčová

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Jarmila SzilasiováDepartment of Neurology, Pavol Jozef Šafárik University, Košice, Slovak Republic.
Jakub Gazda2nd Department of Internal Medicine, Pavol Jozef Šafárik University, L. Pasteur University Hospital, Trieda SNP 1, Košice, 04011, Slovak Republic. jakub.gazda@upjs.sk.ORCID http://orcid.org/0000-0003-2246-2217
Pavol MikulaDepartment of Social and Behavioral Medicine, Pavol Jozef Šafárik University, Košice, Slovak Republic.
Anna CvengrošováDepartment of Neurology, J. A. Reiman Faculty Hospital, Prešov, Slovak Republic.
Miriam FedičováDepartment of Neurology, L. Pasteur University Hospital, Košice, Slovak Republic.
Viera HančinováDepartment of Neurology, University Hospital, Bratislava Ružinov, Slovak Republic.
Ema KantorováDepartment of Neurology, University Hospital, Martin, Slovak Republic.
Martin KarlíkDepartment of Neurology, L. Dérer University Hospital Bratislava, Bratislava, Slovak Republic.
Slavomíra KováčováDepartment of Neurology, Faculty Hospital, Nitra, Slovak Republic.
University of Pavol Jozef Šafárik · SKUniversity Hospital Bratislava · SKIman University · YEMartin University Hospital · SKUniverzitná Nemocnica Louisa Pasteura · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuromyelitis optica spectrum disorders (NMOSD) are autoantibody-mediated inflammatory diseases of the central nervous system predominantly targeting optic nerves and the spinal cord. Two distinct phenotypes are recognized based on the presence of serum aquaporin-4 (AQP4-IgG) antibodies. However, contrasting clinical course patterns have been identified between AQP4-IgG-positive and AQP4-IgG-negative patients.

aimsThis study aimed to present demographic and clinical characteristics of patients with NMOSD in Slovakia and to evaluate the significance of differences between AQP4-IgG-seropositive and AQP4-IgG-seronegative patients.

methodsWe performed a longitudinal multi-centric retrospective study and analysed the clinical and demographic characteristics of a cohort of 63 Slovak NMOSD patients.

resultsEighty-six percent of patients were women, and ninety-four patients were Caucasian. The median age at diagnosis was 37 years. The most frequent initial manifestations were optic neuritis (47.6% of patients) and transverse myelitis (39.7% of patients). The median EDSS score deteriorated from the initial 3.0 to 4.0 at the last follow-up. Sixty-eight percent of patients were AQP4-IgG positive; 10% of patients were MOG-IgG positive; 27% of patients had no NMOSD-specific antibodies detected. There was a higher prevalence of autoimmune thyroiditis among AQP4-IgG-positive patients (25.6%) compared to AQP4-IgG-negative patients (0%) (p = 0.01).

conclusionThis study provides a detailed overview of the clinical and demographic characteristics of NMOSD based on a retrospective analysis of a Slovak cohort of 63 NMOSD patients and extends information provided by similar recently published studies. The most important finding is that there is a high prevalence of autoimmune thyroiditis among AQP4-IgG-negative patients (25%).

Indexed as

Hashimoto DiseaseNeuromyelitis OpticaAdultAquaporin 4AutoantibodiesDemographyFemaleHumansImmunoglobulin GMaleMyelin-Oligodendrocyte GlycoproteinRetrospective StudiesSlovakiaAquaporin 4AutoantibodiesImmunoglobulin GMyelin-Oligodendrocyte GlycoproteinAnti-myelin oligodendrocyte glycoprotein antibodiesAquaporin-4 antibodiesAutoimmune thyroiditisNeuromyelitis optica spectrum disorderNMOSD

Identifiers

PMID37698786
OpenAlexW4386623610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.